
Healthcare AI stocks have fallen sharply in 2026, with declines between 30% and 65%, even as their underlying technologies and partnerships advance. Seven notable healthcare AI companies trading under $50 show strong fundamentals like revenue growth, strategic collaborations, and product development, suggesting potential for significant long-term gains. However, risks such as dilution, regulatory challenges, and execution uncertainties remain. Investors are advised to research thoroughly and consider these factors before investing.